Year: 2025

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

Written by Customer Service on November 13, 2025. Posted in Public Companies.

MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the pricing of an underwritten registered direct offering of 4,189,000 shares of its common stock at a price of $1.11 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase 7,523,000 shares of common stock at an offering price of $1.1099 per pre-funded warrant, which represents the per share offering price for the shares of common stock less the $0.0001 per share exercise price. The gross proceeds to TELA from the offering, before deducting underwriting discounts and estimated offering expenses, are expected to be approximately $13.0 million, assuming no exercise of the pre-funded...

DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025

Written by Customer Service on November 13, 2025. Posted in Public Companies.

BROSSARD, Quebec, Nov. 13, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces that it intends to extend the exercise period of an aggregate of 3,502,931 stock warrants (each a “Warrant”) issued as part of a non-brokered private placement of units initially announced on June 5, 2024 and set to expire on December 5, 2025. Subject to the TSX Venture Exchange (the “Exchange”) consent, the extended expiry date shall be August 5, 2026 (the “Amendment”). All other provisions of the Warrants, such as the Warrants exercise price of $0.40 per common share of the Corporation, will remain unchanged and fully in effect during the extended exercise period. The...

Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations

Written by Customer Service on November 13, 2025. Posted in Earnings Releases And Operating Results.

Sales Revenue Up 135% over Q3 2024 FORT MILL, S.C., Nov. 13, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on the cardiac electrophysiology marketplace, today reported its results of operations for the quarter and nine months ended September 30, 2025. Highlights of the quarter and nine months include: Financial HighlightsTotal revenue reported for Q3 2025 was $226,000, an increase of 135% compared with $96,000 in Q3 2024. Total revenue was $581,000 for the nine months ended September 30, 2025, compared with $271,000 for the nine months ended September 30, 2024, an increase of 114%. GAAP net loss for Q3 2025 was $2,251,000, a 45% reduction compared to $4,120,000 in Q3 2024. GAAP net loss for the nine months ended September 30, 2025 and 2024 was $11,405,000,...

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

Written by Customer Service on November 13, 2025. Posted in Earnings Releases And Operating Results.

Presented new data at the Society of Immunotherapy for Cancer (SITC) annual meeting on CLD-401 protection from immune clearance after systemic administration; data also demonstrates that the platform can effectively express genetic medicines at the tumor site Established new Scientific Advisory Board to support development of CLD-401 and advance RedTail platform for the systemic delivery of targeted genetic medicine Continued expansion of RedTail platform capabilities with multiple additional payloads and programable membrane targeting, further advancing virotherapy in cancer and beyond oncology Raised $6.9 million gross proceeds through an underwritten public offering with new and existing investors that further strengthens the company’s balance sheet and extends its runwaySAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Calidi...

Innventure Reports Third Quarter 2025 Results

Written by Customer Service on November 13, 2025. Posted in Earnings Releases And Operating Results.

Accelsius recently secured strategic investment from Johnson Controls and introduced its NeuCool® MR250 system; pipeline of opportunities now exceeds $1 billion AeroFlexx delivered 5th consecutive quarter of revenue generation with growing customer pipeline in U.S. and Europe Refinity on track to demonstrate pilot scale and finalize initial site selection for first plant by year-end ORLANDO, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) — Innventure, Inc. (NASDAQ: INV) (“Innventure”), an industrial growth conglomerate, today announced financial results for the quarter ended September 30, 2025. “Innventure’s momentum continued in the third quarter, driven by meaningful execution across our operating companies. Accelsius, AeroFlexx, and Refinity each advanced key commercial and technical milestones, reinforcing our belief that Innventure...

Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Written by Customer Service on November 13, 2025. Posted in Earnings Releases And Operating Results.

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today reported financial results for the quarter ended September 30, 2025, and highlighted recent achievements. “As we continue to advance our pipeline, we are entering an important period for Alumis. Our teams have been working diligently, and we are eagerly anticipating key milestones ahead – with topline Phase 3 ONWARD data for envudeucitinib (envu) in moderate-to-severe plaque psoriasis (PsO) expected to be announced early in the first quarter of 2026, followed by topline Phase 2b LUMUS data in systemic lupus erythematosus (SLE) in the third quarter,” said Martin Babler, President and Chief Executive...

Sienna Reports Third Quarter 2025 Financial Results and Continues Growth in Greater Toronto Area

Written by Customer Service on November 13, 2025. Posted in Earnings Releases And Operating Results.

MARKHAM, Ontario, Nov. 13, 2025 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced its financial results for the three and nine months ended September 30, 2025. HighlightsAverage Same Property Occupancy in retirement segment up 230 basis points (“bps”) year over year, and 200 bps quarter over quarter, to 94.1% in Q3 2025, further increasing to 94.7% in October 2025 Same Property Net Operating Income (“NOI”), excluding One-Time Items, up 9.7% year-over-year to $46.4 million in Q3 2025 Retirement Segment up 13.2% year-over-year in Q3 2025 Long-Term Care (“LTC”) Segment up 6.7% year-over year in Q3 2025Adjusted Funds from Operations (“AFFO”), excluding One-Time Items, increased by 36.1% year-over-year, or by 12.0% on a per share basis, in Q3 2025 AFFO Payout Ratio, excluding...

Astrotech Reports First Quarter of Fiscal Year 2026 Financial Results

Written by Customer Service on November 13, 2025. Posted in Earnings Releases And Operating Results.

AUSTIN, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the first quarter of fiscal year 2026, which ended September 30, 2025. Financial Highlights & Recent Developments Revenue increased to $297 thousand or 35% in the first quarter of fiscal year 2026 as compared to the fourth quarter of fiscal year 2025 as Astrotech’s subsidiary, 1st Detect, had more grant revenue and sold more consumables compared to prior quarter. As of September 30, 2025, the Company has deployed the TRACER 1000 in approximately 34 locations in 16 countries across the United States, Europe and Asia. On August 18, 2025, the Company announced that the Board of Directors of the Company had appointed Mr. Nihanth Badugu as Chief Operating Officer of the Company...

Caliber Reports Third Quarter 2025 Financial Results

Written by Customer Service on November 13, 2025. Posted in Earnings Releases And Operating Results.

Transformational Quarter Strengthens Balance Sheet, Launches LINK-Anchored Digital Asset Treasury, and Positions Caliber on Path to Adjusted EBITDA Profitability SCOTTSDALE, Ariz., Nov. 13, 2025 (GLOBE NEWSWIRE) — Caliber (Nasdaq: CWD), a diversified real estate and digital asset management platform, today reported results for the third quarter ended on September 30, 2025. Third Quarter 2025 HighlightsRaised more than $30.0 million through common and preferred equity, strengthening Caliber’s balance sheet and liquidity. Launched Caliber’s Digital Asset Treasury (“DAT”) anchored in Chainlink (LINK) tokens, expanding the Company’s business into digital asset management alongside its core Private Equity Real Estate (PERE) platform.Third Quarter 2025 Platform Financial Results (compared to Third Quarter 2024)Platform revenue...

United Community Banks, Inc. Announces Quarterly Cash Dividend On Common Stock

Written by Customer Service on November 13, 2025. Posted in Dividend Reports And Estimates.

GREENVILLE, S.C., Nov. 13, 2025 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (“United”, the “Company”), reported that its Board of Directors approved a quarterly cash dividend of $0.25 per share on the Company’s common stock. The dividend is payable on January 5, 2026 to shareholders of record as of December 15, 2025. About United Community Banks, Inc.United Community Banks, Inc. (NYSE: UCB) is the financial holding company for United Community, a top 100 U.S. financial institution committed to building stronger communities and improving the financial health and well-being of its customers. United Community offers a full range of banking, mortgage and wealth management services. As of September 30, 2025, United Community Banks, Inc. had $28.1 billion in assets and operated 199 offices across Alabama, Florida, Georgia,...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals